Browse Drug Recalls
3,458 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 3,458 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 3,458 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 26, 2017 | Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500... | CGMP Deviations: Lack of quality assurance at the API manufacturer. | Class II | American Pharmaceutical Ingredients LLC |
| May 2, 2017 | Famotidine for Oral Suspension USP, 40 mg/5 mL, 50 mL bottle, Rx only, Manufa... | CGMP Deviations | Class III | Lupin Pharmaceuticals Inc. |
| Apr 19, 2017 | Estradiol 20 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count an... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 12.5 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count,... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 10 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 1... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 22 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, ... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 18 mg pellet , 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 25 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, ... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Estradiol 6 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 19, 2017 | Shield and Protect Moisture Barrier Cream, 1.1% Clotrimazole, Net Weight 4 oz... | GMP Deviations; product may not meet cGMP requirements | Class II | Gentell, Inc |
| Apr 19, 2017 | Estradiol 15 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 1... | CGMP deviations- Lack of Quality Assurance | Class II | Qualgen |
| Apr 17, 2017 | ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC:... | cGMP Deviations; lack of quality assurance. | Class II | American Pharmaceutical Ingredients LLC |
| Apr 17, 2017 | EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, table... | CGMP deviations: Lots were recalled due to sub-potency and cGMP violations. | Class II | Syntho Pharmaceuticals, Inc. |
| Apr 17, 2017 | EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,10... | CGMP deviations: Lots were recalled due to sub-potency and cGMP violations. | Class II | Syntho Pharmaceuticals, Inc. |
| Apr 13, 2017 | Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Pl... | CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall n... | Class II | Spectrum Laboratory Products, Inc. |
| Apr 13, 2017 | Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg con... | CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall n... | Class II | Spectrum Laboratory Products, Inc. |
| Apr 6, 2017 | Estrone, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-... | cGMP Deviations: lack of quality assurance at the API manufacturer. | Class II | Fagron, Inc |
| Apr 6, 2017 | Estriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-... | cGMP Deviations: lack of quality assurance at the API manufacturer. | Class II | Fagron, Inc |
| Apr 3, 2017 | ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 gram... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-08... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Mar 24, 2017 | Estriol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estradiol Micronized Bulk, Rx only, For Prescription Compounding, Manufacture... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estradiol Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, M... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compoundin... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compoundi... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 8, 2017 | Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free... | CGMP Deviations | Class II | Isomeric Pharmacy Solution, LLC |
| Feb 28, 2017 | Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicat... | CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots. | Class III | G & W Laboratories, Inc. |
| Feb 16, 2017 | HealthA2Z CHEWABLE Aspirin (NSAID) 81 mg, Orange Flavor, 36 Chewable Tablets,... | cGMP deviations - presence of rubber particles found loose in the bulk product. | Class II | Allegiant Health |
| Feb 10, 2017 | REVERSE DML LOTION (Ketoconazole 2%, Metronidazole 2%, sulfacetamide sodium 1... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | LP CREAM (Lidocaine 15%/Prilocaine 5%), Rx only, Synergy RX, 4901 Morena Blvd... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | CUSTOM LIGHTENING/BRIGHTENING CREAM, Rx only, Synergy RX, 4901 Morena Blvd # ... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | TRI-BLEACHING CREAM (Retinoic Acid 0.1%, Hydroquinone 4%, Fluocinolone 0.01%)... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | HYDROCORTISONE 2.5% WITH ALOE VERA CREAM, Rx only, Synergy RX, 4901 Morena Bl... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | CLOBETASOL 0.05% IN OLEA BASE, CLOBETASOL 0.05% IN OROBASE, CLOBETASOL 0.05% ... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | INTIMATE BLEACHING CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San D... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | HYDROQUINONE 28% SOLUTION, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San ... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | KOJIC ACID 8%/AZELAIC ACID 15% CREAM, Rx only, Synergy RX, 4901 Morena Blvd #... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | ULTRA LITE CREAM (Hydroquinone 8%), Rx only, Synergy RX, 4901 Morena Blvd # 5... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | CLARIFYING CREAM (Retinoic acid 0.025%, Salicylic Acid 1%, Green tea powder, ... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | HYDROQUINONE CREAM in all strengths including 4%, 5%,6%, 7%, 8%, HYDROQUINON... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | GENTLE SUPREME BLEACHING CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | HCG in all strength including: 2,400, 9600,12,000 UNIT POWDER VIAL DROPS, HCG... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | ROSACEA CREAM ( Metronidazole 1%, Niacinamide 4%), Rx only, Synergy RX, 4901 ... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | ENHANCED RETIN ANTI-WRINKLE CREAM, ENHANCED RETIN ANTI-WRINKLE CREAM 0.1%, EN... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | UREA 40% Cream, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 9... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
| Feb 10, 2017 | AZELAIC ACID 15% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Die... | Lack of Assurance of Sterility: There are also CGMP Deviations. | Class II | Synergy Rx |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.